Dietary ellagic acid blocks inflammation-associated atherosclerotic plaque formation in cholesterol-fed apoE-deficient mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Atherosclerosis particularly due to high circulating level of low-density lipoprotein is a major cause of cardiovascular diseases. Ellagic acid is a natural polyphenolic compound rich in pomegranates and berries. Our previous study showedthat ellagic acid improved functionality of reverse cholesterol transport in murine modelof atherosclerosis. The aim of this study is to investigate whether ellagic acid inhibited inflammation-associated atherosclerotic plaque formation in cholesterol-fed apolipoprotein E (apoE)-knockout (KO) mice. MATERIALS/METHODS: Wild type mice and apoE-KO mice were fed a cholesterol-rich Paigen diet for 10 weeks to induce severe atherosclerosis. Concurrently, 10 mg/kg ellagic acid was orally administered to the apoE-KO mice. Plaque lesion formation and lipid deposition were examined by staining with hematoxylin and eosin, Sudan IV and oil red O. RESULTS: The plasma leukocyte profile of cholesterol-fed mice was not altered by apoE deficiency. Oral administration of ellagic acid attenuated plaque lesion formation and lipid deposition in the aorta tree of apoE-KO mice. Ellagic acid substantially reduced plasma levels of soluble vascular cell adhesion molecule and interferon-γ in Paigen diet-fed apoE-KO mice. When 10 mg/kg ellagic acid was administered to cholesterol-fed apoE-KO mice, the levels of CD68 and MCP-1 were strongly reduced in aorta vessels. The protein expression level of nitric oxide synthase-2 (NOS2) in the aorta was highly enhanced by supplementation of ellagic acid to apoE-KO mice, but the expression level of heme oxygenase-1 (HO-1) in the aortawas reduced. Furthermore, ellagic acid diminished the increased aorta expression of the inflammator y adhesion molecules in cholesterol-fed apoE-KO mice. The treatment of ellagic acid inhibited the scavenger receptor-B1 expression in the aorta of apoE-KO mice, while the cholesterol efflux-related transporters were not significantly changed. CONCLUSION: These results suggest that ellagic acid may be an atheroprotective compound by attenuating apoE deficiency-induced vascular inflammation and reducing atherosclerotic plaque lesion formation.
Abstract
BACKGROUND/OBJECTIVES: Atherosclerosis particularly due to high circulating level of low-density lipoprotein is a major cause of cardiovascular diseases. Ellagic acid is a natural polyphenolic compound rich in pomegranates and berries. Our previous study showedthat ellagic acid improved functionality of reverse cholesterol transport in murine modelof atherosclerosis. The aim of this study is to investigate whether ellagic acid inhibited inflammation-associated atherosclerotic plaque formation in cholesterol-fed apolipoprotein E (apoE)-knockout (KO) mice. MATERIALS/METHODS: Wild type mice and apoE-KO mice were fed a cholesterol-rich Paigen diet for 10 weeks to induce severe atherosclerosis. Concurrently, 10 mg/kg ellagic acid was orally administered to the apoE-KO mice. Plaque lesion formation and lipid deposition were examined by staining with hematoxylin and eosin, Sudan IV and oil red O. RESULTS: The plasma leukocyte profile of cholesterol-fed mice was not altered by apoE deficiency. Oral administration of ellagic acid attenuated plaque lesion formation and lipid deposition in the aorta tree of apoE-KO mice. Ellagic acid substantially reduced plasma levels of soluble vascular cell adhesion molecule and interferon-γ in Paigen diet-fed apoE-KO mice. When 10 mg/kg ellagic acid was administered to cholesterol-fed apoE-KO mice, the levels of CD68 and MCP-1 were strongly reduced in aorta vessels. The protein expression level of nitric oxide synthase-2 (NOS2) in the aorta was highly enhanced by supplementation of ellagic acid to apoE-KO mice, but the expression level of heme oxygenase-1 (HO-1) in the aortawas reduced. Furthermore, ellagic acid diminished the increased aorta expression of the inflammator y adhesion molecules in cholesterol-fed apoE-KO mice. The treatment of ellagic acid inhibited the scavenger receptor-B1 expression in the aorta of apoE-KO mice, while the cholesterol efflux-related transporters were not significantly changed. CONCLUSION: These results suggest that ellagic acid may be an atheroprotective compound by attenuating apoE deficiency-induced vascular inflammation and reducing atherosclerotic plaque lesion formation.
참고문헌 (45)
- Fazio S, "Mouse models of hyperlipidemia and atherosclerosis", Front Biosci, 6, pp.D515~25 (2001)
- Meir KS, "Atherosclerosis in the apolipoprotein-E-deficient mouse : a decade of progress", Arterioscler Thromb Vasc Biol, 24, pp.1006~1014 (2004)
- Nakashima Y, "ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree", Arterioscler Thromb, 14, pp.133~140 (1994)
- Lee YT, "Mouse models of atherosclerosis : a historical perspective and recent advances", Lipids Health Dis, 16, pp.12~ (2017)
- Mahdinia E, "Cellular crosstalk in atherosclerotic plaque microenvironment", Cell Commun Signal, 21, pp.125~ (2023)
- Rafieian-Kopaei M, "Atherosclerosis : process, indicators, risk factors and new hopes", Int J Prev Med, 5, pp.927~946 (2014)
- Jebari-Benslaiman S, "Pathophysiology of atherosclerosis", Int J Mol Sci, 23, pp.3346~ (2022)
- Mehu M, "Inflammatory cells in atherosclerosis", Antioxidants, 11, pp.233~ (2022)
- Bennett MR, "Vascular smooth muscle cells in atherosclerosis", Circ Res, 118, pp.692~702 (2016)
- Johnson JL, "Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse", Atherosclerosis, 154, pp.399~406 (2001)
- Jawien J, "The role of an experimental model of atherosclerosis : apoE-knockout mice in developing new drugs against atherogenesis", Curr Pharm Biotechnol, 13, pp.2435~2439 (2012)
- Kobiyama K, "Atherosclerosis", Circ Res, 123, pp.1118~1120 (2018)
- Katsuda S, "Atherosclerosis and extracellular matrix", J Atheroscler Thromb, 10, pp.267~274 (2003)
- Farahi L, "Roles of macrophages in atherogenesis", Front Pharmacol, 12, pp.785220~ (2021)
- Lee-Rueckert M, "Lipid-laden macrophages and inflammation in atherosclerosis and cancer : an integrative view", Front Cardiovasc Med, 9, pp.777822~ (2022)
- Kong P, "Inflammation and atherosclerosis : signaling pathways and therapeutic intervention", Signal Transduct Target Ther, 7, pp.131~ (2022)
- Engelen SE, "Therapeutic strategies targeting inflammation and immunity in atherosclerosis : how to proceed", Nat Rev Cardiol, 19, pp.522~542 (2022)
- Li B, "Inflammation : a novel therapeutic target", direction in atherosclerosis, 2017, pp.23, 1216~1227
- Ziółkiewicz A, "The Influence of polyphenols on atherosclerosis development", Int J Mol Sci, 24, pp.7146~ (2023)
- de Araújo FF, "Polyphenols and their applications : an approach in food chemistry and innovation potential", Food Chem, 338, pp.127535~ (2021)
- Lee WJ, "Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells", J Vasc Surg, 52, pp.1290~1300 (2010)
- Larrosa M, "Ellagitannins, ellagic acid and vascular health", Mol Aspects Med, 31, pp.513~539 (2010)
- Park SH, "Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages", J Nutr, 141, pp.1931~1937 (2011)
- Lawrie A, "Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner", Am J Pathol, 179, pp.1693~1705 (2011)
- Getz GS, "Diet and murine atherosclerosis", Arterioscler Thromb Vasc Biol, 26, pp.242~249 (2006)
- Miyoshi T, "Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice", Life Sci, 79, pp.525~531 (2006)
- Detmers PA, "Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice", J Immunol, 165, pp.3430~3435 (2000)
- Nakashima Y, "Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse", Arterioscler Thromb Vasc Biol, 18, pp.842~851 (1998)
- Mu W, "Expression of vascular cell adhesion molecule-1 in the aortic tissues of atherosclerotic patients and the associated clinical implications", Exp Ther Med, 10, pp.423~428 (2015)
- Joyce CW, "The ATP binding cassette transporter A1(ABCA1)modulates the development of aortic atherosclerosis in C57BL", 6 and apoE-knockout mice, 2002, pp.99, 407~412
- Zadelaar S, "Mouse models for atherosclerosis and pharmaceutical modifiers", Arterioscler Thromb Vasc Biol, 27, pp.1706~1721 (2007)
- Curtiss LK, "ApoE in atherosclerosis : a protein with multiple hats", Arterioscler Thromb Vasc Biol, 20, pp.1852~1853 (2000)
- Ilhan F, "Atherosclerosis and the role of immune cells", World J Clin Cases, 3, pp.345~352 (2015)
- Voloshyna I, "Atherosclerosis and interferon-γ : new insights and therapeutic targets", Trends Cardiovasc Med, 24, pp.45~51 (2014)
- Yamashita T, "Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease", J Cardiol, 66, pp.1~8 (2015)
- Hedin U, "Recent advances in therapeutic targeting of inflammation in atherosclerosis", J Vasc Surg, 69, pp.944~951 (2019)
- Loke WM, "Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction", Arterioscler Thromb Vasc Biol, 30, pp.749~757 (2010)
- Park SH, "Purple perilla frutescens extracts containing α-asarone inhibit inflammatory atheroma formation and promote hepatic HDL cholesterol uptake in dyslipidemic apoE-deficient mice", Nutr Res Pract, 17, pp.1099~1112 (2023)
- Park SH, "Ellagic acid, a functional food component, ameliorates functionality of reverse cholesterol transport in murine model of atherosclerosis", Nutr Res Pract, 18, pp.194~209 (2024)
- Campbell NK, "Regulation of inflammation by the antioxidant haem oxygenase 1", Nat Rev Immunol, 21, pp.411~425 (2021)
- Ulyanova T, "Oxidative stress induces heme oxygenase-1 immunoreactivity in Müller cells of mouse retina in organ culture", Invest Ophthalmol Vis Sci, 42, pp.1370~1374 (2001)
- Chiang SK, "The role of HO-1 and its crosstalk with oxidative stress in cancer cell survival", Cells, 10, pp.2401~ (2021)
- Moore KJ, "Macrophages in atherosclerosis : a dynamic balance", Nat Rev Immunol, 13, pp.709~721 (2013)
- Tabas I, "Subendothelial lipoprotein retention as the initiating process in atherosclerosis : update and therapeutic implications", Circulation, 116, pp.1832~1844 (2007)
- Huang L, "SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis", Nature, 569, pp.565~569 (2019)